Literature DB >> 9921945

Spontaneous regression of hepatocellular carcinoma confirmed by surgical specimen: report of two cases and review of the literature.

E Stoelben1, M Koch, S Hanke, A Lossnitzer, H J Gaertner, K U Schentke, A Bunk, H D Saeger.   

Abstract

Two cases with spontaneous regression of a histologically confirmed hepatocellular carcinoma (HCC) are presented. This rarely seen phenomenon of a spontaneous tumor involution is discussed and compared with the current literature. The clinical symptoms were very similar to that of a liver abscess. A 56-year-old male suffered from a multicentric, highly differentiated, trabecular HCC. First symptoms were epigastric pain, septic fever and arthritis. The tumor marker AFP was constantly normal and no hepatitis could be verified. A resection of the tumor was performed. In patient 2, a 74-year-old male, a multicentric, clear cell HCC was found. The patient had completely recovered from hepatitis type B and within the liver tissue no viruses could be identified. Clinical symptoms were mainly characterized by upper abdominal pain and septic fever. AFP was excessively elevated (3850 ng/ml) but returned to normal preoperatively. In both cases, the specimen showed a subtotal necrotic HCC with insignificant amounts of vital tumor cells. Neither patient had a liver cirrhosis macroscopically, however patient 2 had local periportal fibrosis histologically. After 24 and 41 months of follow-up, respectively, both patients are in good health

Entities:  

Mesh:

Year:  1998        PMID: 9921945     DOI: 10.1007/s004230050158

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  10 in total

Review 1.  Spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature.

Authors:  Susana Oquiñena; Mercedes Iñarrairaegui; Juan J Vila; Felix Alegre; Jose M Zozaya; Bruno Sangro
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

Review 2.  Spontaneous regression of hepatocellular carcinoma: report of a case.

Authors:  Hiroshi Ohtani; Osamu Yamazaki; Mitsuharu Matsuyama; Katsuhiko Horii; Sadatoshi Shimizu; Hiroko Oka; Hiroko Nebiki; Kiyohide Kioka; Osamu Kurai; Yasuko Kawasaki; Takao Manabe; Katsuko Murata; Ryoichi Matsuo; Takeshi Inoue
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 3.  Spontaneous regression of pancreatic cancer: real or a misdiagnosis?

Authors:  Marta Herreros-Villanueva; Elizabeth Hijona; Angel Cosme; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Quantitative implementation of the endogenous molecular-cellular network hypothesis in hepatocellular carcinoma.

Authors:  Gaowei Wang; Xiaomei Zhu; Jianren Gu; Ping Ao
Journal:  Interface Focus       Date:  2014-06-06       Impact factor: 3.906

Review 5.  Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response.

Authors:  Jonathan I Huz; Marcovalerio Melis; Umut Sarpel
Journal:  HPB (Oxford)       Date:  2012-05-15       Impact factor: 3.647

6.  Management considerations for purported spontaneous regression of hepatocellular carcinoma: a case report.

Authors:  Takahide Sasaki; Daisuke Fukumori; Kentaroh Yamamoto; Fumio Yamamoto; Hirotsune Igimi; Yuichi Yamashita
Journal:  Case Rep Gastroenterol       Date:  2013-03-20

7.  Spontaneous massive necrosis of hepatocellular carcinoma with narrowing and occlusion of the arteries and portal veins.

Authors:  Takahiro Tomino; Yo-Ichi Yamashita; Tomohiro Iguchi; Shinji Itoh; Mizuki Ninomiya; Toru Ikegami; Tomoharu Yoshizumi; Yuji Soejima; Hirofumi Kawanaka; Tetsuo Ikeda; Shinichi Aishima; Ken Shirabe; Yoshihiko Maehara
Journal:  Case Rep Gastroenterol       Date:  2014-04-24

Review 8.  Spontaneous regression of hepatocellular carcinoma: A mini-review.

Authors:  Akira Sakamaki; Kenya Kamimura; Satoshi Abe; Atsunori Tsuchiya; Masaaki Takamura; Hirokazu Kawai; Satoshi Yamagiwa; Shuji Terai
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

9.  Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.

Authors:  Marina G Tarakanovskaya; Jigjidsuren Chinburen; Purev Batchuluun; Chogsom Munkhzaya; Genden Purevsuren; Dorjiin Dandii; Tsogkhuu Hulan; Dandii Oyungerel; Galyna A Kutsyna; Alan A Reid; Vika Borisova; Allen I Bain; Vichai Jirathitikal; Aldar S Bourinbaiar
Journal:  J Hepatocell Carcinoma       Date:  2017-04-12

10.  CT demonstration of the spontaneous regression of a hypervascular lesion in cirrhotic liver.

Authors:  A Luciani; A Rahmouni; H Achab; D Mathieu; N Jazaerli; M Bouanane
Journal:  Cancer Imaging       Date:  2001-02-01       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.